Marieke van Rosmalen

Chapter 7 124 REFERENCES 1. Oaklander A, Lunn M, Hughes R, et al. Treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): An overview of systematic reviews. Cochrane Database Syst. Rev. 2017;13:1–33. 2. van Schaik I, van den Berg L, de Haan R, Vermeulen M. Intravenous immunoglobulin for multifocal motor neuropathy. Cochrane Database Syst. Rev. 2005;2:920–921. 3. Herraets I, van Rosmalen MH, Bos J, et al. Clinical outcomes in multifocal motor neuropathy: A combined cross-sectional and follow-up study. Neurology 2020;95:e1979– e1987. 4. Van Asseldonk JTH, Van den Berg LH, Van den Berg-Vos RM, et al. Demyelination and axonal loss in multifocal motor neuropathy: Distribution and relation to weakness. Brain 2003;126:186–198. 5. Vucic S, Black K, Baldassari LE, et al. Long- term effects of intravenous immunoglobulin in CIDP. Clin. Neurophysiol. 2007;118:1980– 1984. 6. Iijima M, Yamamoto M, Hirayama M, et al. Clinical and electrophysiologic correlates of IVIg responsiveness in CIDP. Neurology 2005;64:1471–1475. 7. Zaidman CM, Pestronk A. Nerve Size in CIDP Varies with Disease Activity and Therapy Response Over Time: A Retrospective Ultrasound Study. Muscle Nerve 2014;50:733– 738. 8. Telleman J, Herraets I, Goedee H, et al. Prognostic value of nerve ultrasound: a prospective multicenter study on the natural history of polyneuropathy. Eur. J. Neurol. 2021;28:2327–2338. 9. Song SK, Sun SW, Ramsbottom MJ, et al. Dysmyelination revealed through MRI as increased radial (but unchanged axial) diffusion of water. Neuroimage 2002;17:1429–1436. 10. Song SK, Sun SW, JuWK, et al. Diffusion tensor imaging detects and differentiates axon and myelin degeneration in mouse optic nerve after retinal ischemia. Neuroimage 2003;20:1714– 1722. 11. Morisaki S, Kawai Y, Umeda M, et al. In vivo assessment of peripheral nerve regeneration by diffusion tensor imaging. J. Magn. Reson. Imaging 2011;33:535–542. 12. Jeon T, Fung MM, Koch KM, et al. Peripheral nerve diffusion tensor imaging: Overview, pitfalls, and future directions. J. Magn. Reson. Imaging 2018;47:1171–1189. 13. Nowranghi M, Lyketsos C, Leoutsakos J-M, et al. Longitudinal, region-specific course of diffusion tensor imaging measures in mild cognitive impairment and Alzheimer’s disease. Bone 2013;9:519–528. 14. Kitamura S, Kiuchi K, TaokaT, et al. Longitudinal white matter changes in Alzheimer’s disease: A tractography-based analysis study. Brain Res. 2013;1515:12–18. 15. Genc S, Steward CE, Malpas CB, et al. Short- term white matter alterations in Alzheimer’s disease characterized by diffusion tensor imaging. J. Magn. Reson. Imaging 2016;43:627– 634. 16. Mayo CD, Mazerolle EL, Ritchie L, et al. Longitudinal changes in microstructural white matter metrics in Alzheimer’s disease. NeuroImage Clin. 2017;13:330–338. 17. Sampedro F, Martínez-Horta S, Marín-Lahoz J, et al. Longitudinal intracortical diffusivity changes in de-novo Parkinson’s disease: A promising imaging biomarker. Park. Relat. Disord. 2019;68:22–25. 18. Tringale K, Nguyen T, Bahrami N, et al. Identifying early diffusion imaging biomarkers of regional white matter injury as indicators of executive function decline following brain radiotherapy: A prospective clinical trial in primary brain tumor patients. Radiother Oncol 2019;132:27–33. 19. van der Burgh HK, Westeneng HJ, Walhout R, et al. Multimodal longitudinal study of structural